NIH-funded research NIH-funded research

Investigating how structural racism affects kidney health in Black individuals with specific genetic risks

Official title: Structural Racism as a "Third hit" on kidney outcomes of Black individuals with APOL1 risk alleles

Funded at Icahn School of Medicine at Mount Sinai · NIH-11097370 · Data updated 2026-11-12

This study is looking at how structural racism affects kidney health in Black individuals with certain genetic risks, and it aims to find ways to improve care for those facing chronic kidney disease and kidney failure.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startMay 23, 2024
Project endMarch 19, 2025
Funding year2025
Award (this year)$194,886
NIH project number5K23DK139454-02
Project IDNIH-11097370 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are Black individuals with APOL1 high-risk alleles who are experiencing or at risk for chronic kidney disease.

Less likely to help

Patients who do not identify as Black or do not carry APOL1 high-risk alleles may not benefit from this research.

What this research studies

This research explores the impact of structural racism on kidney health outcomes among Black individuals who carry high-risk APOL1 alleles. It aims to understand how this form of racism, alongside other health risks like hypertension and HIV, contributes to the progression of chronic kidney disease (CKD) and kidney failure. The study will involve collaboration with a diverse group of stakeholders to analyze data and develop a patient-centered intervention designed to improve health outcomes. By addressing these complex factors, the research seeks to provide insights that could lead to better care strategies for affected individuals.

Why it matters

Potential benefit: If successful, this research could lead to improved health interventions that mitigate the negative effects of structural racism on kidney health for Black individuals.

How similar studies have gone: While the specific focus on structural racism as a third hit in kidney health is novel, related research has shown that addressing social determinants of health can improve health outcomes in marginalized populations.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Mohottige, Dinushika — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Mohottige, Dinushika

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.